We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 4,327 results
  1. Establishment of a 6-OHDA Induced Unilaterally Lesioned Male Wistar Rat Model of Parkinson’s Disease

    Robust preclinical models of Parkinson’s disease (PD) are valuable tools for understanding the biology and treatment of this complex disease....
    Namrata Kumari, Pratibha Mehta Luthra in Neuroprotection
    Protocol 2024
  2. Restraint Stress Exacerbates Apoptosis in a 6-OHDA Animal Model of Parkinson Disease

    Activation of the apoptotic pathway has been associated with promoting neuronal cell death in the pathophysiology of Parkinson disease (PD)....

    Sara El Idrissi, Nada Fath, ... Oualid Abboussi in Neurotoxicity Research
    Article 12 January 2023
  3. Protective effects of unsaponifiable matter of rice bran and γ-oryzanol on 6-OHDA-induced reactive oxygen species and apoptosis in PC12 cells

    Objective

    Tremor, stiffness, difficulty walking and disturbance in the balance and coordination of movement are the main characteristics of...

    Zahra Tayarani-Najaran, Nilufar Hajizadeh, ... Elham Hadipour in Toxicology and Environmental Health Sciences
    Article 17 February 2024
  4. PACAP/PAC1-R activation contributes to hyperalgesia in 6-OHDA-induced Parkinson’s disease model rats via promoting excitatory synaptic transmission of spinal dorsal horn neurons

    Pain is a common annoying non-motor symptom in Parkinson’s disease (PD) that causes distress to patients. Treatment for PD pain remains a big...

    Li-guo Dong, Meng-qi An, ... Chun-feng Liu in Acta Pharmacologica Sinica
    Article 10 August 2023
  5. Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease

    The feeding-related hormone, acyl-ghrelin, protects dopamine neurones in murine 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-based models...

    Daniel Rees, Amy L. Beynon, ... Jeffrey S. Davies in Cellular and Molecular Neurobiology
    Article Open access 15 September 2022
  6. The Effects of Chronic Marijuana Administration on 6-OHDA-Induced Learning & Memory Impairment and Hippocampal Dopamine and Cannabinoid Receptors Interaction in Male Rats

    There are general inhibitory effects of exo-cannabinoids on dopamine-mediated behaviors. Many studies suggested the interaction between cannabinoid...

    Elham Haghparast, Vahid Sheibani, ... Nahid Sepehri Rad in Neurochemical Research
    Article 09 March 2023
  7. Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson’s disease

    Background

    New data are accumulating on gut microbial dysbiosis in Parkinson’s disease (PD), while the specific mechanism remains uncharacterized....

    Jianjun Yu, Jianhong Meng, ... Dongmei Min in Journal of Neuroinflammation
    Article Open access 19 May 2023
  8. COA-Cl Evokes Protective Responses Against H2O2-and 6-OHDA-Induced Toxic Injury in PC12 Cells

    COA-Cl, a novel adenosine-like nucleic acid analog, has recently been shown to exert neuroprotective effects and to increase dopamine levels both in...

    Mostofa Jamal, Ikuko Tsukamoto, ... Hiroshi Kinoshita in Neurotoxicity Research
    Article 26 November 2022
  9. Citronellol Prevents 6-OHDA-Induced Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Parkinson Disease Model of SH-SY5Y Cells via Modulating ROS-NO, MAPK/ERK, and PI3K/Akt Signaling Pathways

    Parkinson disease is a neurodegenerative disorder distinguished by dopaminergic shortage in the striatum and the accumulation of α-synuclein neuronal...

    Jiahui Shao, Xuan Liu, ... Youbing Mao in Neurotoxicity Research
    Article 12 September 2022
  10. Tyrosinyl-amantadine: A New Amantadine Derivative With an Ameliorative Effect in a 6-OHDA Experimental Model of Parkinson’s Disease in Rats

    The neuroprotective capacity of newly synthesized amantadine derivative tyrosinyl-amantadine (Tyr-Am) with expected antiparkinsonian properties was...

    Maria Lazarova, Lyubka Tancheva, ... Reni Kalfin in Journal of Molecular Neuroscience
    Article 28 January 2022
  11. Continuous dopaminergic stimulation counteracts l-DOPA-induced overactivity of Ca2+ in 6-OHDA-lesioned rats

    In the clinical treatment of Parkinson’s disease (PD), the emergence of l -DOPA-induced dyskinesia (LID) and other motor symptoms remains a...

    Jie Fu, **nyu Zhao, ... **n Yu in Experimental Brain Research
    Article 14 June 2022
  12. Aerobic exercise improves motor function and striatal MSNs-Erk/MAPK signaling in mice with 6-OHDA-induced Parkinson’s disease

    In Parkinson’s disease (PD) state, with progressive loss of dopaminergic neurons in the substantia nigra, the striatal dopamine (DA) and glutamate...

    **aodong Wang, Yinhao Wang, ... Wei Chen in Experimental Brain Research
    Article 06 April 2022
  13. Behavioral and neurochemical interactions of the tricyclic antidepressant drug desipramine with L-DOPA in 6-OHDA-lesioned rats. Implications for motor and psychiatric functions in Parkinson’s disease

    Rationale

    The pharmacological effects of antidepressants in modulating noradrenergic transmission as compared to serotonergic transmission in a rat...

    Kinga Kamińska, Tomasz Lenda, ... Elżbieta Lorenc-Koci in Psychopharmacology
    Article Open access 30 September 2022
  14. The density of calretinin striatal interneurons is decreased in 6-OHDA-lesioned mice

    Interneurons play a significant role in the functional organization of the striatum and some of them display marked plastic changes in...

    S. Petryszyn, L. Saidi, ... M. Parent in Brain Structure and Function
    Article 20 May 2021
  15. Exercise increases striatal Glu reuptake and improves motor dysfunction in 6-OHDA-induced Parkinson’s disease rats

    The purpose of this study is to clarify that exercise may improve the motor dysfunction of Parkinson’s disease (PD) model rats by increasing the...

    Yan Feng, Shifang Zhou, Jian Sun in Experimental Brain Research
    Article 31 August 2021
  16. Beneficial Effect of Melatonin on Motor and Memory Disturbances in 6-OHDA-Lesioned Rats

    Previous evidence has shown a link between neurodegenerative diseases, including Parkinson's disease (PD), and melatonin. The data in the literature...

    Lyubka Tancheva, Maria Lazarova, ... Atanas G. Atanasov in Journal of Molecular Neuroscience
    Article 05 January 2021
  17. Generation of Mitochondrial Toxin Rodent Models of Parkinson’s Disease Using 6-OHDA , MPTP , and Rotenone

    Several animal models are employed to discover novel treatments for the symptoms of Parkinson’s disease (PD). PD models can be divided into two...
    Hiroharu Maegawa, Hitoshi Niwa in Experimental Models of Parkinson’s Disease
    Protocol 2021
  18. FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson’s Disease

    Parkinson’s disease (PD) is a neurodegenerative disorder characterized by degeneration of dopaminergic neurons associated with dysregulation of iron...

    Ye Tian, Juan Lu, ... Meiling Zhu in Neurotherapeutics
    Article 21 September 2020
  19. The effect of URB597, exercise or their combination on the performance of 6-OHDA mouse model of Parkinson disease in the elevated plus maze, tail suspension test and step-down task

    Parkinson disease (PD) is a progressive neurodegenerative disorder that is often accompanied by motor and psychiatric symptoms. Various approaches...

    Mohaddeseh Ebrahimi-Ghiri, Faezeh Shahini, Mohammad-Reza Zarrindast in Metabolic Brain Disease
    Article 02 October 2021
  20. Adenosine A1 and A2A receptors are involved on guanosine protective effects against oxidative burst and mitochondrial dysfunction induced by 6-OHDA in striatal slices

    6-Hydroxydopamine (6-OHDA) is the most used toxin in experimental Parkinson’s disease (PD) models. 6-OHDA shows high affinity for the dopamine...

    C. M. Massari, L. C. Constantino, C. I. Tasca in Purinergic Signalling
    Article 06 February 2021
Did you find what you were looking for? Share feedback.